Bsyde adds BonLeven partnership, expands advisory board for migraine care

By AI, Created 5:20 PM UTC, May 20, 2026, /AGP/ – Bsyde said May 21 it is expanding its AI migraine platform through a new partnership with BonLeven Healthcare and three additions to its medical advisory board. The move is meant to push migraine care toward continuous monitoring, reimbursable care models and wider clinical adoption.

Why it matters: - Bsyde is positioning its platform as a way to move migraine care beyond occasional office visits and toward continuous management. - The BonLeven rollout gives the company a real clinical setting to test workflows, monitoring and reimbursement support. - The partnership could matter for specialty clinics that want higher-touch migraine care without building the technology stack from scratch.

What happened: - Bsyde announced a strategic partnership with BonLeven Healthcare on May 21, 2026. - BonLeven will deploy Bsyde’s technology across its clinics. - Bsyde also expanded its medical advisory board with Dr. Julio Vega, Dr. Luis Diaz and Dr. Nilay Shah. - The company said BonLeven will use Bsyde as its primary technology platform for migraine management. - Sean Clottu, Bsyde’s founder, said the partnership is meant to support more connected and continuous care.

The details: - Bsyde is an AI-powered digital health platform focused on continuous migraine care. - Migraine affects more than 40 million people in the United States. - BonLeven treats hundreds of migraine patients each year. - The partnership is designed to bring continuous patient monitoring and data-driven insights into daily clinical practice. - Bsyde said the model is aligned with how care is delivered and reimbursed in the real world. - The expanded advisory board includes physicians across neurology and internal medicine. - Nilay Shah, MD, FAAN, is medical director at BonLeven and brings expertise in neurology and clinical neurophysiology. - Julio Vega, MD, is a neurologist and interventional pain specialist at BonLeven and brings expertise in headache care, clinical neurophysiology, neuromodulation and technology-enabled care innovation. - Luis Diaz, MD, is a board-certified internal medicine physician at BonLeven and brings a perspective on chronic disease management and patient-centered care delivery. - The advisory board will guide clinical strategy, product development and real-world implementation across care settings. - The BonLeven partnership is aligned with reimbursable care models, including Principal Care Management (PCM). - Bsyde said it plans to expand into Remote Therapeutic Monitoring (RTM) and Chronic Care Management (CCM). - The collaboration is intended to create a scalable framework for broader adoption across specialty clinics. - The model is designed to support reimbursable continuous care programs. - Bsyde said the goal is to help providers sustainably deliver higher-touch migraine care while improving patient engagement, outcomes and continuity of care. - Bsyde’s contact page directs providers to bsyde.ai. - BonLeven’s website is bonleven.com.

Between the lines: - The partnership signals Bsyde is trying to turn migraine care software into a reimbursement-friendly clinical workflow, not just a patient app. - Adding physicians from BonLeven to the advisory board also ties product development more closely to day-to-day specialty care. - The emphasis on PCM, RTM and CCM suggests Bsyde is building around payment pathways as much as around clinical features.

What’s next: - Bsyde said the BonLeven model is meant to serve as a scalable template for other specialty clinics. - The company is seeking broader provider interest as it expands clinical partnerships and its advisor network. - Future growth is expected to focus on deeper workflow integration and expansion into additional reimbursable care programs.